Steroid Use Could Raise Diabetes Risk

Madrid: Taking steroids more than doubles a person’s risk of developing type 2 diabetes, a new study warns.

Patients taking steroid pills, injections or infusions are 2.6 times more likely to develop diabetes than those not on steroids, researchers reported Sunday in a presentation at the annual meeting of the European Association for the Study of Diabetes in Madrid.

The results of this large-scale study confirm suspicions that the effects of steroids on blood sugar levels can boost diabetes risk, researchers said.

“Existing information on how much more common new diabetes is in patients treated with glucocorticoids is based on small studies including patients with one or a few conditions,” said lead researcher Dr. Rajna Golubic, a lecturer in diabetes and endocrinology with the University of Oxford. “We wanted to expand the data to get a more accurate idea of how likely it is that people could develop diabetes while being treated with these drugs.”

Steroids are used to treat a wide range of medical problems by helping quell inflammation. These include asthma, rheumatoid arthritis, inflammatory bowel disease and cancer.

Unfortunately, the drugs also increase blood sugar levels by reducing insulin sensitivity and interfering with cells’ ability to absorb glucose, according to Diabetes UK.

To see whether this effect on blood sugar could cause diabetes, the research team analyzed data on more than 450,000 people treated between 2013 and 2023 by Oxford University Hospitals.

None of the people had diabetes at the start of the study, and none were taking steroids.

During the period of the study, nearly 4% of the patients began taking steroids while in the hospital, including prednisone, hydrocortisone and dexamethasone.

Of all the patients, about 2% of those taking steroids wound up with type 2 diabetes, compared with fewer than 1% of those who didn’t receive steroids, researchers found.

When age and sex were factored in, steroids increased people’s risk of diabetes by 2.6 times, researchers concluded.

“These latest results give clinical staff a better estimate of how likely new diabetes is to occur and could prompt doctors to plan clinical care more effectively to detect and manage new diabetes,” Golubic said.

People regularly taking steroids for asthma and arthritis should be monitored for diabetes, Golubic added.

Because these findings were presented at a medical meeting, they should be considered preliminary until published in a peer-reviewed journal.

Related Posts

  • Pharma
  • July 16, 2025
  • 148 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 48 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients